Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular Imaging

Lung cancer is the leading cause of cancer-related death worldwide. Most targeted drugs approved for lung cancer treatment are tyrosine kinase inhibitors (TKIs) directed against EGFR or ALK, and are used mainly for adenocarcinoma. At present, there is no effective or tailored targeting agent for lar...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Yi-Hsuan, Hsiao, Jong-Kai, Lin, Ming-Huang, Chang, Chen, Lan, Chun-Hsin, Wu, Han-Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436516/
https://www.ncbi.nlm.nih.gov/pubmed/28529640
http://dx.doi.org/10.7150/thno.17573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436516/
https://www.ncbi.nlm.nih.gov/pubmed/28529640
http://dx.doi.org/10.7150/thno.17573

Ejemplares similares